MPM

Clinical trials for MPM explained in plain language.

Never miss a new study

Get alerted when new MPM trials appear

Sign up with your email to follow new studies for MPM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New antibody-chemo combo shows promise for mesothelioma

Disease control Completed

This study tested a new drug called PM8002, which targets two proteins that help cancer grow, combined with standard chemotherapy. It involved 31 adults with a rare cancer called malignant mesothelioma that could not be removed by surgery. The goal was to see if the combination s…

Matched conditions: MPM

Phase: PHASE2 • Sponsor: Biotheus Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:05 UTC

MPM

Get alerted when new MPM trials appear

New antibody-chemo combo shows promise for mesothelioma